Program 6 Month Injectable For Cats Patent Expiration

Program 6 Month Injectable For Cats is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2015. All patents have expired. Details of Program 6 Month Injectable For Cats’s patents and their expiration are given below.

Filter patents by

Drug Patent Number Drug Patent Expiry Status
Patent Data
US5776982 Active

About Program 6 Month Injectable For Cats

Program 6 Month Injectable For Cats is a drug owned by ELANCO US INC. Program 6 Month Injectable For Cats uses Lufenuron as the active ingredient.

Active Ingredient:

Program 6 Month Injectable For Cats uses Lufenuron as the active ingredient. Check out other Drugs and Companies using Lufenuron ingredient.